GLYCOMIMETICS INC (GLYC)

US38000Q1022 - Common Stock

1.74  +0.12 (+7.41%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
10.00K80.00K1.16M10.16M0.00
Operating Expenses
39.29M47.48M64.61M61.67M61.39M
Research and Development
20.07M28.39M47.49M44.93M47.03M
Selling, General, and Administrative Expenses
19.21M19.09M17.12M16.74M14.36M
Operating Income
-39.28M-47.40M-63.45M-51.51M-61.39M
Interest Income/Expense
2.38M710.00K20.00K480.00K3.50M
Income Before Taxes
-36.90M-46.69M-63.43M-51.03M-57.89M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-36.90M-46.69M-63.43M-51.03M-57.89M
EBITDA
-39.12M-47.19M-63.19M-51.24M-61.11M
 
Per Share Data
EPS Diluted Total Ops
-0.58-0.89-1.23-1.12-1.34
Non GAAP EPS
-0.58-0.88-1.23-1.11-1.35
 
Statistics
Profit Margin
-368994.20%-58362.50%-5468.10%-502.26%N/A
Operating Profit Margin
-392752.90%-59250.00%-5469.83%-506.99%N/A

All data in USD

Charts